piyasalar Cuma, 24 Nisan 2026 0,00

Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing loss

Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it will charge in other countries.

Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing loss basliginda one cikan gelisme: Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it will charge in other countries.

Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.

Orijinal kaynak: CNBC

Paylaş: